Investigating novel thiazolyl-indazole derivatives as scaffolds for SARS-CoV-2 MPro inhibitors
COVID-19 is a global pandemic caused by infection with the SARS-CoV-2 virus. Remdesivir, a SARS-CoV-2 RNA polymerase inhibitor, is the only drug to have received widespread approval for treatment of COVID-19. The SARS-CoV-2 main protease enzyme (MPro), essential for viral replication and transcripti...
Saved in:
Main Authors: | Justin Airas (Author), Catherine A. Bayas (Author), Abdellah N'Ait Ousidi (Author), Moulay Youssef Ait Itto (Author), Aziz Auhmani (Author), Mohamed Loubidi (Author), M'hamed Esseffar (Author), Julie A. Pollock (Author), Carol A. Parish (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design, Synthesis and Anticandidal Evaluation of Indazole and Pyrazole Derivatives
by: Karen Rodríguez-Villar, et al.
Published: (2021) -
Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds-synthesis, biological activity, and structural evaluation
by: Piotr Stępnicki, et al.
Published: (2023) -
Synthesis, Cytotoxicity and Antioxidant Activity Evaluation of Some Thiazolyl-Catechol Compounds
by: Alexandra Cătălina Cornea, et al.
Published: (2024) -
Synthesis, antimicrobial and antioxidant activities of pyridyl substituted thiazolyl triazole derivatives
by: Naime Funda Tay, et al.
Published: (2022) -
About standardization of L-lysinum 3-methyl-1,2,4-thiazolyl-5-thioacetate tablets
by: O. S. Bidnenko, et al.
Published: (2016)